z-logo
Premium
Pseudoporphyria and Nonsteroidal Antiinflammatory Agents in Children with Juvenile Idiopathic Arthritis
Author(s) -
De Silva Bernadette,
Banney Leith,
Uttley William,
Luqmani Raashid,
Schofield Olivia
Publication year - 2000
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1046/j.1525-1470.2000.01827.x
Subject(s) - medicine , naproxen , nonsteroidal , dermatology , etiology , arthritis , erythema , juvenile , prospective cohort study , juvenile rheumatoid arthritis , rheumatology , alternative medicine , pathology , biology , genetics
Pseudoporphyria is characterized by erythema, blistering, and scarring on sun‐exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1‐year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here